Evidence map›Paper›PMID 38037567›Full record

ArticleStatistica Sinica2023

HETEROGENEITY ANALYSIS VIA INTEGRATING MULTI-SOURCES HIGH-DIMENSIONAL DATA WITH APPLICATIONS TO CANCER STUDIES.

Tingyan Zhong, Qingzhao Zhang, Jian Huang, Mengyun Wu, Shuangge Ma

Abstract read
In one paragraph

Article in Statistica Sinica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tingyan ZhongSJTU-Yale Joint Center for Biostatistics, Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Qingzhao ZhangSchool of Economics and Wang Yanan Institute for Studies in Economics, Xiamen University, Fujian, China.
Jian HuangDepartment of Applied Mathematics, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
Mengyun WuSchool of Statistics and Management, Shanghai University of Finance and Economics, Shanghai, China.
Shuangge MaDepartment of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT 06520-0834, USA.

Funding

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Kurt A Schalper · 2015 to 2026
$31.1M
Novel methods for identifying genetic interactions in cancer prognosisR01CA204120 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2016 to 2026
$3.5M
Integrated Cancer Modeling: A New DimensionR03CA241699 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2019 to 2020
$168k
NCI NIH HHS P50 CA196530NCI NIH HHS R01 CA204120NCI NIH HHS R03 CA241699
6 · The paper itself

Abstract

This study has been motivated by cancer research, in which heterogeneity analysis plays an important role and can be roughly classified as unsupervised or supervised. In supervised heterogeneity analysis, the finite mixture of regression (FMR) technique is used extensively, under which the covariates affect the response differently in subgroups. High-dimensional molecular and, very recently, histopathological imaging features have been analyzed separately and shown to be effective for heterogeneity analysis. For simpler analysis, they have been shown to contain overlapping, but also independent information. In this article, our goal is to conduct the first and more effective FMR-based cancer heterogeneity analysis by integrating high-dimensional molecular and histopathological imaging features. A penalization approach is developed to regularize estimation, select relevant variables, and, equally importantly, promote the identification of independent information. Consistency properties are rigorously established. An effective computational algorithm is developed. A simulation and an analysis of The Cancer Genome Atlas (TCGA) lung cancer data demonstrate the practical effectiveness of the proposed approach. Overall, this study provides a practical and useful new way of conducting supervised cancer heterogeneity analysis.

Indexed as

Cancer heterogeneitydata integrationFMRmolecular and imaging features

Identifiers

PMID38037567
PMCPMC10686523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.